Companies
/
Injective Protocol
Fintech
Injective is a blockchain network specifically designed for building decentralized finance applications, including exchanges, derivatives, and prediction markets, with fast transaction speeds and low fees.
Create an account to view live offerings, pricing, and market activity.
Sign in to view offerings and live market activity.
Injective was founded in 2018 by Eric Chen and Albert Chon, building a blockchain specifically optimized for financial applications, at a time when most decentralized finance (DeFi) applications, meaning blockchain-based financial products such as trading exchanges and lending platforms that operate without traditional centralized financial intermediaries, were built on top of general-purpose blockchains like Ethereum, which the founders argued were not originally designed with the specific speed, cost, and functionality requirements that sophisticated financial applications like derivatives trading and order-book-based exchanges need to function well. Injective's blockchain is built using the Cosmos SDK, a software framework for building custom, purpose-specific blockchains that can still interoperate with other blockchains in the broader Cosmos ecosystem, and is specifically optimized to support decentralized financial applications requiring fast transaction finality and low fees, including on-chain order book-based exchanges, which differ from the automated market maker model used by many other decentralized exchanges and can better support more sophisticated trading strategies and derivatives products similar to those found on traditional centralized financial exchanges. The network has positioned itself as infrastructure specifically for developers building sophisticated DeFi applications, including perpetual futures exchanges, prediction markets, and other financial products that benefit from Injective's speed and financial-application-specific technical design, rather than being a general-purpose blockchain intended to support arbitrary applications the way networks like Ethereum aim to support. Injective has built interoperability with other major blockchain ecosystems, including Ethereum and other Cosmos-based chains, letting assets and applications move relatively easily between Injective and these other networks. The project's native INJ token is used for network transaction fees, governance voting on protocol changes, and securing the network through a staking mechanism common to many proof-of-stake blockchains. Injective has raised venture funding from investors including Pantera Capital, Jump Crypto, and Mark Cuban, positioning itself within the competitive landscape of specialized Layer 1 blockchains built for decentralized finance applications.
FOR QUALIFIED INSTITUTIONAL AND ACCREDITED INVESTORS ONLY: Under federal securities laws, private market investments on this platform are available exclusively to Institutional and Accredited Investors. Verification of status required before investing. Private investments involve significant risks including illiquidity, potential loss of principal, and limited disclosure requirements. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, not a bank or financial institution. Cash Accounts are provided by Modern Treasury Corp. financial institution partners and through Augment's technology. Augment does not act as a money services business, provide money transmission, or serve as a custodian of funds. Funds held in your Cash Account are not FDIC insured unless expressly disclosed. Full terms available in the Augment Cash Account Agreement. Brokerage services are offered through Augment Capital, LLC, an affiliated broker-dealer and member FINRA/SIPC. "Investment accounts" are not brokerage accounts and do not hold customer funds or securities. Investment advisory services are offered through Augment Advisors, LLC, an SEC-registered investment adviser. Registration with the SEC does not imply a certain level of skill or training. Neither Augment Advisors, LLC nor Augment Capital, LLC provide legal or tax advice; consult your attorney or tax professional regarding your specific situation. For additional information, please refer to Augment Advisors, LLC's Form ADV Part 2A (Firm Brochure) and FINRA BrokerCheck.
No news available for this company.
